Use of Intravitreal Dexamethasone in a Case of Anterior Ischemic Optic Neuropathy
Nowadays there is no unique and well-established treatment for nonarteritic anterior ischemic optic neuropathy, despite being the main acute pathology that affects the optic nerve in the elderly population and often resulting in a significant loss of visual acuity. The effectiveness of oral steroids...
Main Authors: | Raffaele Nuzzi, Francesca Monteu |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-08-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/479785 |
Similar Items
-
Efficacy of Dexamethasone intravitreal implant in treating non-arteritic anterior ischemic optic neuropathy
by: Qiu-Pu Zhao, et al.
Published: (2022-03-01) -
Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
by: Berry S, et al.
Published: (2017-09-01) -
An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
by: Vivek Pravin Dave, et al.
Published: (2016-01-01) -
The Effect of Intravitreal Injection of Erythropoietin in Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy
by: Alireza Dehghani, et al.
Published: (2017-04-01) -
Clinical profile and predictors of visual outcome in nonarteritic anterior ischemic optic neuropathy
by: P T Jyothi, et al.
Published: (2018-01-01)